Copyright Reports & Markets. All rights reserved.

Global Prescription Dermatological Medications Market Growth 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Prescription Dermatological Medications Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Prescription Dermatological Medications Consumption 2014-2024
        • 2.1.2 Prescription Dermatological Medications Consumption CAGR by Region
      • 2.2 Prescription Dermatological Medications Segment by Type
        • 2.2.1 Oral
        • 2.2.2 Topical
      • 2.3 Prescription Dermatological Medications Consumption by Type
        • 2.3.1 Global Prescription Dermatological Medications Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Prescription Dermatological Medications Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Prescription Dermatological Medications Sale Price by Type (2014-2019)
      • 2.4 Prescription Dermatological Medications Segment by Application
        • 2.4.1 Hospital Pharmacies
        • 2.4.2 Online Pharmacies
        • 2.4.3 Retail Pharmacies
      • 2.5 Prescription Dermatological Medications Consumption by Application
        • 2.5.1 Global Prescription Dermatological Medications Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Prescription Dermatological Medications Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Prescription Dermatological Medications Sale Price by Application (2014-2019)

      3 Global Prescription Dermatological Medications by Players

      • 3.1 Global Prescription Dermatological Medications Sales Market Share by Players
        • 3.1.1 Global Prescription Dermatological Medications Sales by Players (2017-2019)
        • 3.1.2 Global Prescription Dermatological Medications Sales Market Share by Players (2017-2019)
      • 3.2 Global Prescription Dermatological Medications Revenue Market Share by Players
        • 3.2.1 Global Prescription Dermatological Medications Revenue by Players (2017-2019)
        • 3.2.2 Global Prescription Dermatological Medications Revenue Market Share by Players (2017-2019)
      • 3.3 Global Prescription Dermatological Medications Sale Price by Players
      • 3.4 Global Prescription Dermatological Medications Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Prescription Dermatological Medications Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Prescription Dermatological Medications Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Prescription Dermatological Medications by Regions

      • 4.1 Prescription Dermatological Medications by Regions
        • 4.1.1 Global Prescription Dermatological Medications Consumption by Regions
        • 4.1.2 Global Prescription Dermatological Medications Value by Regions
      • 4.2 Americas Prescription Dermatological Medications Consumption Growth
      • 4.3 APAC Prescription Dermatological Medications Consumption Growth
      • 4.4 Europe Prescription Dermatological Medications Consumption Growth
      • 4.5 Middle East & Africa Prescription Dermatological Medications Consumption Growth

      5 Americas

      • 5.1 Americas Prescription Dermatological Medications Consumption by Countries
        • 5.1.1 Americas Prescription Dermatological Medications Consumption by Countries (2014-2019)
        • 5.1.2 Americas Prescription Dermatological Medications Value by Countries (2014-2019)
      • 5.2 Americas Prescription Dermatological Medications Consumption by Type
      • 5.3 Americas Prescription Dermatological Medications Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Prescription Dermatological Medications Consumption by Countries
        • 6.1.1 APAC Prescription Dermatological Medications Consumption by Countries (2014-2019)
        • 6.1.2 APAC Prescription Dermatological Medications Value by Countries (2014-2019)
      • 6.2 APAC Prescription Dermatological Medications Consumption by Type
      • 6.3 APAC Prescription Dermatological Medications Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Prescription Dermatological Medications by Countries
        • 7.1.1 Europe Prescription Dermatological Medications Consumption by Countries (2014-2019)
        • 7.1.2 Europe Prescription Dermatological Medications Value by Countries (2014-2019)
      • 7.2 Europe Prescription Dermatological Medications Consumption by Type
      • 7.3 Europe Prescription Dermatological Medications Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Prescription Dermatological Medications by Countries
        • 8.1.1 Middle East & Africa Prescription Dermatological Medications Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Prescription Dermatological Medications Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Prescription Dermatological Medications Consumption by Type
      • 8.3 Middle East & Africa Prescription Dermatological Medications Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Prescription Dermatological Medications Distributors
      • 10.3 Prescription Dermatological Medications Customer

      11 Global Prescription Dermatological Medications Market Forecast

      • 11.1 Global Prescription Dermatological Medications Consumption Forecast (2019-2024)
      • 11.2 Global Prescription Dermatological Medications Forecast by Regions
        • 11.2.1 Global Prescription Dermatological Medications Forecast by Regions (2019-2024)
        • 11.2.2 Global Prescription Dermatological Medications Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Prescription Dermatological Medications Forecast by Type
      • 11.8 Global Prescription Dermatological Medications Forecast by Application

      12 Key Players Analysis

      • 12.1 Mylan Pharmaceuticals
        • 12.1.1 Company Details
        • 12.1.2 Prescription Dermatological Medications Product Offered
        • 12.1.3 Mylan Pharmaceuticals Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Mylan Pharmaceuticals News
      • 12.2 Pfizer
        • 12.2.1 Company Details
        • 12.2.2 Prescription Dermatological Medications Product Offered
        • 12.2.3 Pfizer Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Pfizer News
      • 12.3 Almirall
        • 12.3.1 Company Details
        • 12.3.2 Prescription Dermatological Medications Product Offered
        • 12.3.3 Almirall Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Almirall News
      • 12.4 Bausch Health
        • 12.4.1 Company Details
        • 12.4.2 Prescription Dermatological Medications Product Offered
        • 12.4.3 Bausch Health Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Bausch Health News
      • 12.5 Barrier Therapeutics
        • 12.5.1 Company Details
        • 12.5.2 Prescription Dermatological Medications Product Offered
        • 12.5.3 Barrier Therapeutics Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Barrier Therapeutics News
      • 12.6 PharmaDerm
        • 12.6.1 Company Details
        • 12.6.2 Prescription Dermatological Medications Product Offered
        • 12.6.3 PharmaDerm Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 PharmaDerm News
      • 12.7 Bristol-Myers Squibb
        • 12.7.1 Company Details
        • 12.7.2 Prescription Dermatological Medications Product Offered
        • 12.7.3 Bristol-Myers Squibb Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Bristol-Myers Squibb News
      • 12.8 Galderma
        • 12.8.1 Company Details
        • 12.8.2 Prescription Dermatological Medications Product Offered
        • 12.8.3 Galderma Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Galderma News
      • 12.9 Novartis
        • 12.9.1 Company Details
        • 12.9.2 Prescription Dermatological Medications Product Offered
        • 12.9.3 Novartis Prescription Dermatological Medications Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Novartis News

      13 Research Findings and Conclusion

      Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications.

      According to this study, over the next five years the Prescription Dermatological Medications market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Prescription Dermatological Medications business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Prescription Dermatological Medications market by product type, application, key manufacturers and key regions and countries.

      This study considers the Prescription Dermatological Medications value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      Oral
      Topical
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Hospital Pharmacies
      Online Pharmacies
      Retail Pharmacies

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Mylan Pharmaceuticals
      Pfizer
      Almirall
      Bausch Health
      Barrier Therapeutics
      PharmaDerm
      Bristol-Myers Squibb
      Galderma
      Novartis

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Prescription Dermatological Medications consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Prescription Dermatological Medications market by identifying its various subsegments.
      Focuses on the key global Prescription Dermatological Medications manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Prescription Dermatological Medications with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Prescription Dermatological Medications submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now